Warning: The NCBI web site requires JavaScript to function. more...

An official website of the United States government

Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Account

Logged in as:
username

Dashboard
Publications
Account settings
Log out

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

MeSH

NLM Controlled Vocabulary

Search database

Search term

Create alert
Limits
Advanced
Help

Full

Format

Full
Full (text)
Summary
Summary (text)

Send to:

Choose Destination

File
Clipboard
Collections

Format

Nimustine

Antineoplastic agent especially effective against malignant brain tumors. The resistance which brain tumor cells acquire to the initial effectiveness of this drug can be partially overcome by the simultaneous use of membrane-modifying agents such as reserpine, calcium antagonists such as nicardipine or verapamil, or the calmodulin inhibitor, trifluoperazine. The drug has also been used in combination with other antineoplastic agents or with radiotherapy for the treatment of various neoplasms.

Year introduced: 1989

PubMed search builder options

Subheadings: